Effectiveness of Allergic Rhinitis Management Related to WHO Guideline on Allergic Rhinitis and Its Impact on Asthma (ARIA)

Atika Aziza; Arif Dermawan; Vycke Yunivita Kusumah Dewi

Effectiveness of Allergic Rhinitis Management Related to WHO Guideline on Allergic Rhinitis and Its Impact on Asthma (ARIA)

Atika Aziza, Arif Dermawan, Vycke Yunivita Kusumah Dewi

Abstract

Background: The standard procedure of Allergic Rhinitis (AR) Management in Indonesia is based on Allergic Rhinitis and Its Impact on Asthma (ARIA) World Health Organization (WHO) 2008 guideline; however, it needs some adjustment to get an effective use locally in Indonesia. The data related to the problem however did not exist in Indonesia. The study aimed to evaluate the effectiveness of AR patient management based on the ARIA WHO guideline in the Department of Otorhinolaryngology-Head and Neck Surgery Dr. Hasan Sadikin General Hospital Bandung.

Methods: The study was conducted from September to October 2015 using quantitative descriptive design to observe the development of ARIA classification, total nasal symptom score (TNSS), and quality of life (QoL) during the first 6 months of therapy. The data were obtained from medical records of AR patients who visited the Rhinology-Allergy clinic Department of Otorhinolaryngology-Head and Neck Surgery Dr. Hasan Sadikin General Hospital within one year. Thirty three patients were included in the study using total sampling.

Results: There was significant improvement (p<0.001) in ARIA classification, TNSS, and QoL between the initiation of therapy, the third, and the sixth month. In contrary, there was no significant difference in ARIA classification (p=0.109), TNSS (p=0.317), and QoL (p=1.000) between the third and the sixth month of therapy.

Conclusions: Allergic rhinitis patient management based on the 2008 ARIA WHO guideline is effective. [AMJ.2016;3(4):538–44]

Keywords: Allergic rhinitis, asthma, effectiveness, management

DOI: 10.15850/amj.v3n4.651

Keywords

Allergic rhinitis, asthma, effectiveness, management

Full Text:

PDF

References

Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008. Allergy. 2008;63 (Suppl 86):S8–160.

Achmad Sodikin, Teti Madiadipoera. Karakteristik penderita rinitis alergi sesuai guideline allergic rhinitis and its impact on asthma (ARIA) di bagian THT-KL RS. Hasan Sadikin Bandung periode 1 Januari - 31 Desember 2009. Proceedings of The 6th Jakarta International Functional Endoscopic Sinus Surgery Course and Workshop; 2010 Mar 4-7; Jakarta. Jakarta: Perhimpunan Dokter Ahli THT-KL; 2010.

Katelaris CH, Lai CK, Rhee CS, Lee SH, Yun WD, Lim-Varona L, et al. Nasal allergies in the Asian-Pacific population: results from the allergies in Asia-Pacific survey. Am J Rhinol Allergy. 2011;25 (Suppl 1):S3–15.

Brożek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466–76.

Raissa Mentari Moeis, Melati Sudiro, RB. Soeherman Herdiningrat. Allergic rhinitis patient characteristics in Dr. Hasan Sadikin General Hospital Bandung in Indonesia. AMJ. 2014;1(2):75–80.

Osman M, Hansell AL, Simpson CR, Hollowell J, Helms PJ. Gender-specific presentations for asthma, allergic rhinitis and eczema in primary care. Prim Care Respir J. 2007;16(1):28–35.

Scichilone N, Callari A, Augugliaro G, Marchese M, Togias A, Bellia V. The impact of age on prevalence of positive skin prick tests and specific IgE tests. Respir Med. 2011;105(5):651–8.

Valero A, Izquierdo I, Giralt J, Bartra J, del Cuvillo A, Mullol J. Rupatadine improves nasal symptoms, quality of life (ESPRINT-15) and severity in a subanalysis of a cohort of Spanish allergic rhinitis patients. J Investig Allergol Clin Immunol. 2011;21(3):229–35.

Mullol J, Bartra J, del Cuvillo A, Izquierdo I, Muñoz-Cano R, Valero A. Specialist-based treatment reduces the severity of allergic rhinitis. Clin Exp Allergy. 2013;43(7):723–9.

Dretzke J, Meadows A, Novielli N, Huissoon A, Fry-Smith A, Meads C. Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison. J Allergy Clin Immunol. 2013;131(5):1361–6.

Holmberg K, Tonnel AB, Dreyfus I, Olsson P, Cougnard J, Mesbah K, et al. Desloratadine relieves nasal congestion and improves quality-of-life in persistent allergic rhinitis. Allergy. 2009;64(11):1663–70.

Feng CH, Miller MD, Simon RA. The united allergic airway: Connections between allergic rhinitis, asthma, and chronic sinusitis. Am J Rhinol. 2012;26(3):187–90.

Devillier P, Dreyfus JF, Demoly P, Calderon MA. A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis. BMC Med. 2014;12(1):1–12.

Benninger M, Farrar JR, Blaiss M, Chipps B, Ferguson B, Krouse J, et al. Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class. Ann Allergy Asthma Immunol. 2010;104(1):13–29.